Small-Cell Lung Cancer - Pipeline Review, H1 2018 | Pharmaceuticals Market Analysis & Trends 2018 | JSB Market Research
Summary Small cell lung cancer (SCLC) is a fast-growing type of lung cancer. It spreads much more quickly than non-small cell lung cancer. SCLC is the most aggressive form of lung cancer. It usually starts in the breathing tubes (bronchi) in the center of the chest. These tumors often spread rapidly (metastasize) to other parts of the body, including the brain, liver, and bone. Symptoms of SCLC: Bloody Sputum, Chest Pain, Cough, Loss of Appetite, Weight Loss and Wheezing. Treatment includes: Surgery, Radiation Therapy, Chemotherapy Highlights from this market research report : The latest Pharmaceutical and Healthcare pipeline guide on Small-Cell Lung Cancer - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Small-Cell Lung Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive ...